UNIGENE LABORATORIES INC
10-Q, EX-27, 2000-08-14
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: UNIGENE LABORATORIES INC, 10-Q, EX-10.2, 2000-08-14
Next: FOSTER L B CO, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE>                                       5

<S>                                           <C>
<PERIOD-TYPE>                               6-MOS
<FISCAL-YEAR-END>                     DEC-31-2000
<PERIOD-START>                        JAN-01-2000
<PERIOD-END>                          JUN-30-2000
<CASH>                                    132,046
<SECURITIES>                                    0
<RECEIVABLES>                              44,523
<ALLOWANCES>                                    0
<INVENTORY>                             1,542,826
<CURRENT-ASSETS>                        2,024,283
<PP&E>                                 17,914,993
<DEPRECIATION>                         11,619,014
<TOTAL-ASSETS>                         10,930,625
<CURRENT-LIABILITIES>                   9,898,108
<BONDS>                                 1,054,183
                           0
                                     0
<COMMON>                                  440,440
<OTHER-SE>                              (462,106)
<TOTAL-LIABILITY-AND-EQUITY>           10,930,625
<SALES>                                         0
<TOTAL-REVENUES>                        1,002,026
<CGS>                                           0
<TOTAL-COSTS>                                   0
<OTHER-EXPENSES>                        6,547,543
<LOSS-PROVISION>                                0
<INTEREST-EXPENSE>                        547,203
<INCOME-PRETAX>                        (6,056,205)
<INCOME-TAX>                                    0
<INCOME-CONTINUING>                    (6,056,205)
<DISCONTINUED>                                  0
<EXTRAORDINARY>                                 0
<CHANGES>                                       0
<NET-INCOME>                           (6,056,205)
<EPS-BASIC>                                  (.14)
<EPS-DILUTED>                                (.14)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission